Reduce driveline trauma through stabilization and exit site management: 30 days feasibility results from the multicenter RESIST study

ASAIO Journal

Volumn 62, Issue 3, 2016, Pages 240-245

  Stahovich, Marcia ^a   Sundareswaran, Kartik S ^b   Fox, Sarah ^c   Hallinan, William ^d   Blood, Peggy ^e   Chen, Leway ^d   Pamboukian, Salpy V ^e   Chinn, Raymond ^a   Farrar, David J ^b   Pagani, Francis D ^c   Blue, Laura ^f  

^a SHARP MEMORIAL HOSPITAL   (United States)

^b THORATEC CORPORATION   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e University of Alabama at Birmingham   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

driveline infection; driveline stabilization; exit site trauma; percutaneous lead

Indexed keywords

BIOMATERIALS; BIOPHYSICS;

CHANGE FREQUENCIES; DRIVELINES; LEAD MANAGEMENT; PATIENT COMFORT; SITE MANAGEMENT; STANDARD OF CARES;

STABILIZATION;

2 PROPANOL PLUS CHLORHEXIDINE GLUCONATE; SODIUM CHLORIDE; STERILE SALINE; UNCLASSIFIED DRUG;

ADHESION BARRIER FILM; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRIVELINE INFECTION; FACE MASK; FEASIBILITY STUDY; FEMALE; HAIR COVER; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MALE; MEDICAL DEVICE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT COMFORT; PERCUTANEOUS LEAD MANAGEMENT KIT; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; PROTECTIVE GLOVE; STERILE NONLATEX GLOVE; STYROFOAM TRAY; SURGICAL SWAB; WOUND CARE; WOUND DRESSING; ADVERSE DEVICE EFFECT; CLINICAL TRIAL; DEVICES; HEART ASSIST DEVICE; INFECTION; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; SELF CARE;

ADULT; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; SELF CARE;

EID: 84992293223     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000374     Document Type: Article

References (21)

1. John R Kamdar F Liao K Colvin-Adams M Boyle A Joyce L Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008 86 1227 1234
2. Starling RC Naka Y Boyle AJ Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011 57 1890 1898
3. Jorde UP Kushwaha SS Tatooles AJ HeartMate II Clinical Investigators Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: A prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2014 63 1751 1757
4. Zierer A Melby SJ Voeller RK Late-onset driveline infections: The Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007 84 515 520
5. Nienaber JJ Kusne S Riaz T Mayo Cardiovascular Infections Study Group Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 2013 57 1438 1448
6. Slaughter MS Rogers JG Milano CA HeartMate II Investigators Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 361 2241 2251
7. Pagani FD Miller LW Russell SD HeartMate II Investigators Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009 54 312 321
8. Miller LW Pagani FD Russell SD HeartMate II Clinical Investigators Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007 357 885 896
9. John R Naka Y Smedira NG Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg 2011 92 1406 1413. discussion 1413
10. Myers TJ McGee MG Zeluff BJ Radovancevic B Frazier OH Frequency and significance of infections in patients receiving prolonged LVAD support. ASAIO Trans 1991 37 M283 M285
11. Holman WL Pamboukian SV McGiffin DC Tallaj JA Cadeiras M Kirklin JK Device related infections: Are we making progress? J Card Surg 2010 25 478 483
12. McBride LR Swartz MT Reedy JE Miller LW Pennington DG Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days. ASAIO Trans 1991 37 M258 M259
13. Goldstein DJ Naftel D Holman W Continuous-flow devices and percutaneous site infections: Clinical outcomes. J Heart Lung Transplant 2012 31 1151 1157
14. Dean D Kallel F Ewald GA SSI Registry Investigators Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry. J Heart Lung Transplant 2015 34 781 789
15. Pereda D Conte JV Left ventricular assist device driveline infections. Cardiol Clin 2011 29 515 527
16. Myers TJ Khan T Frazier OH Infectious complications associated with ventricular assist systems. ASAIO J 2000 46 S28 S36
17. Didisheim P Rose EA Long JW Holman WL Burns G Shive MS Infection with clinical ventricular assist devices: Clinical therapy. ASAIO J 2001 47 195 196
18. Silver S Phung le T Silver G Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. J Ind Microbiol Biotechnol 2006 33 627 634
19. Mooney EK Lippitt C Friedman J Plastic Surgery Educational Foundation DATA Committee Silver dressings. Plast Reconstr Surg 2006 117 666 669
20. Epstein NE Preoperative, intraoperative, and postoperative measures to further reduce spinal infections. Surg Neurol Int 2011 2 17
21. Connery SA Downes KL Young C A retrospective study evaluating silver-impregnated dressings on cesarean wound healing. Adv Skin Wound Care 2012 25 414 419